Related Experiment Videos
Evaluation of some acylamide derivatives as potential hypoglycemic agents
V Srivastava1, A J Suresh, S N Pandeya
1Dept. of Pharmaceutics, I.T., Varanasi, India.
Bollettino Chimico Farmaceutico
|July 1, 1996
Summary
New acylamide derivatives containing piperidine, pyrrolidinyl, and alanyl groups show promising hypoglycemic activities. Specifically, 2-(Pyrrolidynyl)-N-(3-chlorophenyl) acetamide and 2-(Piperazinyl)-N-(4-methoxy phenyl) acetamide demonstrated significant blood sugar-lowering effects.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Diabetes mellitus is a global health concern requiring novel therapeutic agents.
- Acylamide derivatives are being explored for their potential pharmacological properties.
Purpose of the Study:
- To synthesize and evaluate novel acylamide derivatives for hypoglycemic activity.
- To identify potent compounds for diabetes management.
Main Methods:
- Synthesis of acylamide derivatives incorporating piperidine, pyrrolidinyl, and alanyl moieties.
- In vitro and/or in vivo testing to assess hypoglycemic effects.
Main Results:
- Several acylamide derivatives were successfully synthesized.
- 2-(Pyrrolidynyl)-N-(3-chlorophenyl) acetamide and 2-(Piperazinyl)-N-(4-methoxy phenyl) acetamide exhibited the most significant hypoglycemic activity.
- The active compounds may share a mechanism of action with sulfonylureas.
Conclusions:
- The novel acylamide derivatives show potential as hypoglycemic agents.
- Further research into their mechanism of action and therapeutic efficacy is warranted.